
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Jobs from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/jobs/topic/2029/</link>
        <description>Articles tagged with Jobs from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Business briefs: Roche, Doximity and Bayer</title>
          <description>Roche is shuttering a division and eliminating 170 jobs; Doximity has added another client; a cautiously-worded study indicates antidepressants may be linked to autism; and NICE has endorsed a new use for Bayer&apos;s Xarelto.</description>
          <link>http://www.mmm-online.com/business-briefs-roche-doximity-and-bayer/article/290194/</link>
          <pubDate>Tue, 23 Apr 2013 17:43:17 GMT</pubDate>
          <itunes:summary>Roche is shuttering a division and eliminating 170 jobs; Doximity has added another client; a cautiously-worded study indicates antidepressants may be linked to autism; and NICE has endorsed a new use for Bayer&apos;s Xarelto.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Business briefs: Chandler Chicco, Pfizer, FDA, Dainippon, CDC</title>
          <description>Gwee exchanges Edelman offices for Chandler Chicco&apos;s, Pfizer can&apos;t shake Celebrex lawsuits, FDA issues draft guidance for biosimilars meetings, Dainippon Sumitomo acquires Edison Pharmaceuticals, CDC reports on growing ADHD diagnoses.</description>
          <link>http://www.mmm-online.com/business-briefs-chandler-chicco-pfizer-fda-dainippon-cdc/article/286813/</link>
          <pubDate>Mon, 01 Apr 2013 15:48:16 GMT</pubDate>
          <itunes:summary>Gwee exchanges Edelman offices for Chandler Chicco&apos;s, Pfizer can&apos;t shake Celebrex lawsuits, FDA issues draft guidance for biosimilars meetings, Dainippon Sumitomo acquires Edison Pharmaceuticals, CDC reports on growing ADHD diagnoses.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>More pink slips at AstraZeneca</title>
          <description>Days after announcing a sharp downsizing, the patent expiry-plagued company said it will eliminate an additional 2,300 jobs, raising the tally of cuts to more than 5,000 through 2016.</description>
          <link>http://www.mmm-online.com/more-pink-slips-at-astrazeneca/article/285381/</link>
          <pubDate>Thu, 21 Mar 2013 15:13:01 GMT</pubDate>
          <itunes:summary>Days after announcing a sharp downsizing, the patent expiry-plagued company said it will eliminate an additional 2,300 jobs, raising the tally of cuts to more than 5,000 through 2016.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Company news: Edelman, Pfizer, Publicis, Lippincott</title>
          <description>Healthcare PR giant Dan Edelman dies; Pfizer says &apos;no comment&apos; on breakup speculation; Publicis Healthcare snags a new SVP; Lippincott gives nurses a new drug diagnosis tool.</description>
          <link>http://www.mmm-online.com/company-news-edelman-pfizer-publicis-lippincott/article/276089/</link>
          <pubDate>Tue, 15 Jan 2013 17:15:17 GMT</pubDate>
          <itunes:summary>Healthcare PR giant Dan Edelman dies; Pfizer says &apos;no comment&apos; on breakup speculation; Publicis Healthcare snags a new SVP; Lippincott gives nurses a new drug diagnosis tool.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Company news: ComScore, Pfizer, J&amp;J</title>
          <description>ComScore finds a trend between ads and prescriptions, Pfizer is courting fewer PCPs, Weldon is out as chair in 2013.</description>
          <link>http://www.mmm-online.com/company-news-comscore-pfizer-jj/article/270966/</link>
          <pubDate>Mon, 03 Dec 2012 18:32:36 GMT</pubDate>
          <itunes:summary>ComScore finds a trend between ads and prescriptions, Pfizer is courting fewer PCPs, Weldon is out as chair in 2013.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Company news: Bristol-Myers Squibb and Regeneron</title>
          <description>Bristol-Myers fires, Regeneron hires.</description>
          <link>http://www.mmm-online.com/company-news-bristol-myers-squibb-and-regeneron/article/268323/</link>
          <pubDate>Wed, 14 Nov 2012 20:49:32 GMT</pubDate>
          <itunes:summary>Bristol-Myers fires, Regeneron hires.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>People news: Boston Scientific, Watson</title>
          <description>Boston Scientific&apos;s new CEO takes office, Watson creates a generics management team</description>
          <link>http://www.mmm-online.com/people-news-boston-scientific-watson/article/266580/</link>
          <pubDate>Thu, 01 Nov 2012 18:22:21 GMT</pubDate>
          <itunes:summary>Boston Scientific&apos;s new CEO takes office, Watson creates a generics management team</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Company news: Pfizer, Johnson &amp; Johnson, TGaS and Roche</title>
          <description>Sandy halts earnings reports and trading, Pfizer and J&amp;J slash headcounts, TGaS to-do&apos;s for market researchers, Roche probed on pharmacovigilance</description>
          <link>http://www.mmm-online.com/company-news-pfizer-johnson-johnson-tgas-and-roche/article/265800/</link>
          <pubDate>Mon, 29 Oct 2012 14:49:12 GMT</pubDate>
          <itunes:summary>Sandy halts earnings reports and trading, Pfizer and J&amp;J slash headcounts, TGaS to-do&apos;s for market researchers, Roche probed on pharmacovigilance</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Abbott lays off 550 as breakup nears</title>
          <description>The company talked R&amp;D investment strategies for the two new companies during its Q3 earnings call, and has also laid off 550 employees.</description>
          <link>http://www.mmm-online.com/abbott-lays-off-550-as-breakup-nears/article/264089/</link>
          <pubDate>Wed, 17 Oct 2012 18:28:25 GMT</pubDate>
          <itunes:summary>The company talked R&amp;D investment strategies for the two new companies during its Q3 earnings call, and has also laid off 550 employees.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>What&apos;s more important to pharma execs? A large paycheck or a great place to work?</title>
          <description>MM&amp;M&apos;s 26th annual Career &amp; Salary Survey is now open. Help us to give you the truest picture of salaries, opportunities, migration, aspirations and opinions within pharma and healthcare marketing.</description>
          <link>http://www.mmm-online.com/whats-more-important-to-pharma-execs-a-large-paycheck-or-a-great-place-to-work/article/256306/</link>
          <pubDate>Sun, 26 Aug 2012 16:00:00 GMT</pubDate>
          <itunes:summary>MM&amp;M&apos;s 26th annual Career &amp; Salary Survey is now open. Help us to give you the truest picture of salaries, opportunities, migration, aspirations and opinions within pharma and healthcare marketing.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  